A Dose-response Study With Strontium Malonate in Postmenopausal Women
NCT00409032
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
275
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoporosis
Interventions
DRUG:
Strontium malonate
Sponsor
Osteologix